Abstract
Amiodarone is an effective antiarrhythmic agent whose use is associated with several drug interactions one of which is potentiation of the action of warfarin. The mechanism of this interaction has hitherto been unclear. We examined possible mechanisms in eight patients. Total plasma warfarin clearance was found to be reduced by amiodarone. No change was detected in the binding of warfarin to plasma proteins. No relationship was found between plasma amiodarone concentrations and the change in warfarin clearance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bjornsson T. D., Blaschke T. F., Meffin P. J. High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin. J Pharm Sci. 1977 Jan;66(1):142–144. doi: 10.1002/jps.2600660144. [DOI] [PubMed] [Google Scholar]
- Graboys T. B., Podrid P. J., Lown B. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Am Heart J. 1983 Oct;106(4 Pt 2):870–876. doi: 10.1016/0002-8703(83)90009-1. [DOI] [PubMed] [Google Scholar]
- Hamer A., Peter T., Mandel W. J., Scheinman M. M., Weiss D. The potentiation of warfarin anticoagulation by amiodarone. Circulation. 1982 May;65(5):1025–1029. doi: 10.1161/01.cir.65.5.1025. [DOI] [PubMed] [Google Scholar]
- Heger J. J., Prystowsky E. N., Zipes D. P. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. Am Heart J. 1983 Oct;106(4 Pt 2):887–894. doi: 10.1016/0002-8703(83)90012-1. [DOI] [PubMed] [Google Scholar]
- Marcus F. I. Drug interactions with amiodarone. Am Heart J. 1983 Oct;106(4 Pt 2):924–930. doi: 10.1016/0002-8703(83)90017-0. [DOI] [PubMed] [Google Scholar]
- McKenna W. J., Rowland E., Krikler D. M. Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) 1983 Dec 3;287(6406):1654–1656. doi: 10.1136/bmj.287.6406.1654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rees A., Dalal J. J., Reid P. G., Henderson A. H., Lewis M. J. Dangers of amiodarone and anticoagulant treatment. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1756–1757. doi: 10.1136/bmj.282.6278.1756-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Serlin M. J., Breckenridge A. M. Drug interactions with warfarin. Drugs. 1983 Jun;25(6):610–620. doi: 10.2165/00003495-198325060-00004. [DOI] [PubMed] [Google Scholar]
- Serlin M. J., Sibeon R. G., Green G. J. Dangers of amiodarone and anticoagulant treatment. Br Med J (Clin Res Ed) 1981 Jul 4;283(6283):58–58. doi: 10.1136/bmj.283.6283.58-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Staiger C., Jauernig R., de Vries J., Weber E. Influence of amiodarone on antipyrine pharmacokinetics in three patients with ventricular tachycardia. Br J Clin Pharmacol. 1984 Aug;18(2):263–264. doi: 10.1111/j.1365-2125.1984.tb02467.x. [DOI] [PMC free article] [PubMed] [Google Scholar]